We observed that adrenocortical cancer cells may gain mesenchymal characteristics, associated with the expression of mesenchymal markers (e.g., N-cadherin and vimentin) as part of the process towards the acquisition of a fully transformed phenotype. The gene discussed is CDH2; the disease is adrenal cortex carcinoma.